Skip to content
Explore expert articles on technology, innovation, and digi…

Zimbabwe Rejects ‘One-Sided’ American Healthcare Assistance Deal Because of Information Concerns

Medical aid illustration
The proposed US financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a significant American health deal worth $367m (272 million pounds) over five years because of the United States' demand for confidential data.

The decision was revealed after a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "skewed".

A government spokesman later clarified that the United States was seeking health data for research and commercial gain but was not willing to share the benefits from future treatments.

"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged further talks to find a agreement suitable to both sides so the country's critical HIV programme can proceed.

Broader Context

This development comes after a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the security of Kenyans' medical information.

After resuming office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.

Based on reports, 16 African countries have so far signed these new health pacts, constituting over $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our population if a future disease outbreak arise."

National Interest and International Frameworks

He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures previously set up via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.

"This framework is intended to guarantee that when a nation provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."

The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome continued discussions with our American counterparts on how future collaboration might be designed in a manner that honours the independence and interests of each country."

Health Experts Reaction

A leading public health body expressed it understood the official position, but recommended that talks need to persist given that much of the nation's HIV programmes depended on international support.

"Where specific concerns arise, including those involving data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group said.

This impasse emphasises the complex tensions between accepting crucial international aid and safeguarding national sovereignty in an increasingly data-driven world.

About the author

Catherine Shepherd

A technology journalist and digital strategist with over a decade of experience covering emerging tech trends and innovation.

HubOpenBlog

Type to search articles.